Ustekinumab for the treatment of psoriatic arthritis: an update

Psoriatic arthritis occurs in 30% of psoriasis patients, and the treatment can be challenging in some patients. Recently, the US Food and Drug Administration approved ustekinumab, a fully human monoclonal antibody, for the management of psoriatic arthritis. In this article, we review large-scale ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Davari, Parastoo, Leo, Michael S, Kamangar, Faranak, Fazel, Nasim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158889/
https://www.ncbi.nlm.nih.gov/pubmed/25214798
http://dx.doi.org/10.2147/CCID.S50003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158889/
https://www.ncbi.nlm.nih.gov/pubmed/25214798
http://dx.doi.org/10.2147/CCID.S50003

Ejemplares similares